R. Schokker

Heidelberg University

Papers

1

Total Citations

2

H-Index

1

About

R. Schokker is a pioneering researcher in the field of interventional oncology and medical robotics, with a primary focus on advancing precision-guided cancer therapies. Their most notable contribution is the development of robotic systems for MR-guided high-dose-rate (HDR) brachytherapy, a technique that delivers targeted radiation to tumors while minimizing damage to surrounding healthy tissue. As the lead author of the landmark "ROBiNSon" study (2024), Schokker demonstrated the feasibility and spatial accuracy of robotic needle implantation for prostate brachytherapy, achieving precise targeting of intraprostatic lesions under real-time MRI guidance. This proof-of-concept work, already garnering early citations, represents a significant step toward automating and improving the accuracy of minimally invasive cancer treatments. Schokker's research bridges the gap between robotics engineering and clinical oncology, with the potential to enhance treatment outcomes for prostate cancer patients. Their work is particularly impactful for researchers and clinicians interested in the intersection of image-guided interventions, robotic-assisted surgery, and radiation oncology, offering a glimpse into the future of personalized, robotically delivered cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic MR-guided high dose rate brachytherapy needle implantation in the prostate (ROBiNSon)—a proof-of-concept study
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Heidelberg University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago